Australia markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1248+0.0182 (+17.07%)
As of 01:49PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
6,051
9,311
15,173
11,815
3,630
Selling general and administrative
4,581
5,485
7,509
9,757
4,514
Total operating expenses
10,632
14,796
22,682
21,572
8,144
Operating income or loss
-10,632
-14,796
-22,682
-21,572
-8,144
Interest expense
-
-
-
26
-
Total other income/expenses net
-9
10
7
-16,606
-1,057
Income before tax
-10,584
-14,649
-22,661
-38,298
-9,126
Income from continuing operations
-10,584
-14,649
-22,661
-38,298
-9,126
Net income
-10,584
-14,649
-22,661
-38,298
-9,126
Net income available to common shareholders
-10,765
-15,019
-25,131
-41,504
-9,143
Basic EPS
-7.71
-9.27
-25.80
-80.00
-43.50
Diluted EPS
-7.71
-9.27
-25.80
-80.00
-43.50
Basic average shares
1,684
1,620
974
517.72
208.88
Diluted average shares
1,684
1,620
974
517.72
208.88